You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,962,028


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,962,028
Title:Topical steroid composition and method
Abstract: Storage stable, topical lotion compositions for treating corticosteroid-responsive dermatoses are provided by the present invention which include a halobetasol material comprising halobetasol or its pharmaceutically acceptable salts, esters, and solvates; and a pharmaceutically acceptable carrier which includes: (a) one or more fatty alcohols and/or one or more alkoxylated fatty alcohols, (b) one or more polyol humectants, and (c) diisopropyl adipate. Storage stable, topical lotion compositions for treating corticosteroid-responsive dermatoses are provided by the present invention which include 0.05% halobetasol propionate; and a pharmaceutically acceptable carrier which includes: (a) one or more fatty alcohols and/or one or more alkoxylated fatty alcohols, (b) one or more polyol humectants, and (c) diisopropyl adipate.
Inventor(s): Johnson; Keith A. (Durham, NC), Popp; Karl F. (Schodack Landing, NY)
Assignee: MiCal Pharmaceuticals LLC--H Series, a Series of MiCal Pharmaceuticals LLC, a Multi-Division Limited Liability Company (San Diego, CA)
Application Number:13/921,833
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,962,028
Patent Claim Types:
see list of patent claims
Use; Composition; Delivery; Formulation; Device;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 8,962,028: A Comprehensive Analysis

Introduction

When analyzing a patent, it is crucial to delve into its scope, claims, and the broader patent landscape to understand its significance, validity, and potential impact. This article will provide a detailed analysis of United States Patent 8,962,028, focusing on its claims, the context within which it was granted, and the relevant legal and technical aspects.

Patent Overview

United States Patent 8,962,028, hereafter referred to as the '028 patent, is a specific intellectual property right granted by the United States Patent and Trademark Office (USPTO). To analyze this patent, one must first identify its key components:

Patent Title and Abstract

The title and abstract of the patent provide a preliminary understanding of the invention. While the specific details of the '028 patent are not provided in the sources, typically, the title and abstract summarize the main invention and its purpose.

Claims

The claims section is the most critical part of a patent as it defines the scope of the invention. Claims can be independent or dependent, with independent claims standing alone and dependent claims referring back to one or more previous claims[3].

Claim Types and Structure

Independent Claims

Independent claims are self-contained and do not rely on other claims. They define the broadest scope of the invention.

Dependent Claims

Dependent claims build upon independent claims or other dependent claims, often narrowing the scope by adding additional limitations.

Claim Language and Interpretation

The language used in claims is precise and technical. Each word and phrase is carefully chosen to ensure the claim is clear and unambiguous. The interpretation of claims is a legal process that can be complex, often requiring expert analysis to determine the exact scope of protection[1].

Patent Scope and Breadth

The scope of a patent is determined by its claims. A broader claim may cover a wider range of embodiments, while narrower claims may be more specific but also more limited in their application.

Patent Scope Measurements

The USPTO has developed datasets and metrics to measure patent scope, including the Patent Claims Research Dataset. This dataset provides detailed information on claims from US patents and applications, helping to analyze the breadth and depth of patent protection[3].

Obviousness and Novelty

Two key criteria for patentability are obviousness and novelty. The '028 patent must have been found to be novel and non-obvious over the prior art at the time of its grant.

Obviousness-Type Double Patenting (ODP)

ODP is a doctrine that prevents an inventor from securing a second, later-expiring patent for an invention that is not significantly different from an earlier patent. This is particularly relevant in cases where patents are continuations-in-part or have overlapping subject matter[1].

Patent Term and Adjustments

The term of a patent can be affected by various factors, including Patent Term Adjustment (PTA) and terminal disclaimers.

Patent Term Adjustment (PTA)

PTA extends the term of a patent to compensate for delays in the USPTO's processing. However, PTA does not extend the term past the date of a terminal disclaimer, which is often used to overcome ODP rejections[1].

Legal and Regulatory Context

Federal Circuit Rulings

Decisions from the Federal Circuit, such as the case of In re Cellect LLC, provide guidance on how to interpret patent laws and regulations, including the handling of ODP and PTA[1].

Section 337 of the Tariff Act

This section deals with unfair practices in import trade, including patent infringement. While not directly related to the '028 patent, it highlights the broader legal landscape in which patents operate[2].

Economic and Practical Implications

Patent Litigation and Enforcement

The validity and scope of a patent can significantly impact litigation and enforcement. A well-defined scope can help in defending against infringement claims or asserting the patent against infringers.

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court, which could simplify and reduce the costs associated with patent litigation for smaller entities[5].

Industry Impact and Trends

Technology Fields

Patents like the '028 patent are often categorized within specific technology fields. Understanding these fields can provide insights into industry trends and the competitive landscape[4].

Public Interest and Stakeholder Input

Public comments and stakeholder input are crucial in shaping patent policies and regulations. This includes feedback on potential small claims patent courts and other reforms aimed at improving the patent system[5].

Key Takeaways

  • Claims Analysis: The claims section of a patent is critical for understanding its scope and breadth.
  • Patent Scope Measurements: Tools like the Patent Claims Research Dataset help in analyzing the scope of patents.
  • Obviousness and Novelty: These are key criteria for patentability and must be carefully evaluated.
  • Patent Term Adjustments: PTA and terminal disclaimers can affect the term of a patent.
  • Legal Context: Federal Circuit rulings and other legal frameworks are essential for interpreting patent laws.
  • Economic Implications: The scope and validity of a patent have significant economic and practical implications.

FAQs

What is the primary purpose of the claims section in a patent?

The primary purpose of the claims section is to define the scope of the invention, distinguishing it from prior art and other inventions.

How does Patent Term Adjustment (PTA) affect the term of a patent?

PTA extends the term of a patent to compensate for delays in the USPTO's processing, but it does not extend the term past the date of a terminal disclaimer.

What is obviousness-type double patenting (ODP)?

ODP is a doctrine that prevents an inventor from securing a second, later-expiring patent for an invention that is not significantly different from an earlier patent.

Why is the Patent Claims Research Dataset important?

The dataset provides detailed information on claims from US patents and applications, helping to analyze the breadth and depth of patent protection.

What is the significance of a small claims patent court?

A small claims patent court could simplify and reduce the costs associated with patent litigation for smaller entities, making the patent system more accessible.

Sources

  1. In re Cellect LLC, United States Court of Appeals for the Federal Circuit, August 28, 2023.
  2. Federal Register, Volume 89 Issue 44, Tuesday, March 5, 2024.
  3. Patent Claims Research Dataset, USPTO, August 28, 2017.
  4. What Is the Probability of Receiving a US Patent?, YJOLT, 2024.
  5. U.S. Patent Small Claims Court, Administrative Conference of the United States, 2022.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,962,028

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Mical Pharms ULTRAVATE halobetasol propionate LOTION;TOPICAL 208183-001 Nov 6, 2015 DISCN Yes No ⤷  Subscribe ⤷  Subscribe Y USE OF A LOTION CONTAINING HALOBETASOL PROPIONATE FOR THE TREATMENT OF CORTICOSTEROID-RESPONSIVE DERMATOSES INCLUDING PSORIASIS ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.